ROCHESTER, N.Y. -Do you know it has been about two and a half years since the last total lunar eclipse? So, it is an unusual astronomical event that is highly dependent on the precise alignment of the sun, Earth and moon.
In this scenario, the visible light from the sun reaches the Earth, but the Earth blocks most of that light from reaching the moon. As a result, the Earth is casting a shadow on the moon. However, it is not a completely dark shadow. As the Sun’s rays pass through our atmosphere, a portion of the light spectrum is filtered with the red color being least affected. This residual light penetrates to the moon creating a reddish hue, hence the name “blood moon”.
Unfortunately, if you really want to see this event, you may lose some sleep. The partial eclipse begins at 1:09 A.M. Friday morning with the maximum eclipse happening close to around 3 A.M. Beyond that point, the eclipse slowly fades into the wee hours of the morning.
The recommendation for viewing is to look towards the south to southwestern sky and if possibly get away from any artificial light. Meteorologically, the other concern is the amount of cloud cover. Right now, the News10NBC First Alert meteorologists are cautiously optimistic the clouds will be minimal over Western New York. But you know that viewing any astronomical event can be a challenge – especially this time of the year.
First Alert Weather In-Depth: Tracking the blood moon WHEC.com.
Hence then, the article about first alert weather in depth tracking the blood moon was published today ( ) and is available on News10NBC ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( First Alert Weather In-Depth: Tracking the blood moon )
Also on site :
- Golfer Masashi ‘Jumbo’ Ozaki dies at 78
- Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
- Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline